102 related articles for article (PubMed ID: 19229863)
1. Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival.
Liu XB; Wang JA; Ogle ME; Wei L
J Cell Biochem; 2009 Apr; 106(5):903-11. PubMed ID: 19229863
[TBL] [Abstract][Full Text] [Related]
2. Dimethyloxaloylglycine Promotes the Angiogenic Activity of Mesenchymal Stem Cells Derived from iPSCs via Activation of the PI3K/Akt Pathway for Bone Regeneration.
Zhang J; Guan J; Qi X; Ding H; Yuan H; Xie Z; Chen C; Li X; Zhang C; Huang Y
Int J Biol Sci; 2016; 12(6):639-52. PubMed ID: 27194942
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Prolyl Hydroxylase Attenuates Fas Ligand-Induced Apoptosis and Lung Injury in Mice.
Nagamine Y; Tojo K; Yazawa T; Takaki S; Baba Y; Goto T; Kurahashi K
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):878-888. PubMed ID: 27494234
[TBL] [Abstract][Full Text] [Related]
4. Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats.
Liu XB; Wang JA; Ji XY; Yu SP; Wei L
Stem Cell Res Ther; 2014 Sep; 5(5):111. PubMed ID: 25257482
[TBL] [Abstract][Full Text] [Related]
5. Prolyl hydroxylase inhibitors delay neuronal cell death caused by trophic factor deprivation.
Lomb DJ; Straub JA; Freeman RS
J Neurochem; 2007 Dec; 103(5):1897-906. PubMed ID: 17760870
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
7. Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells.
Takaku M; Tomita S; Kurobe H; Kihira Y; Morimoto A; Higashida M; Ikeda Y; Ushiyama A; Hashimoto I; Nakanishi H; Tamaki T
PLoS One; 2012; 7(8):e42964. PubMed ID: 22880134
[TBL] [Abstract][Full Text] [Related]
8. Dimethyloxalylglycine preconditioning enhances protective effects of bone marrow-derived mesenchymal stem cells in Aβ- induced Alzheimer disease.
Esmaeilzade B; Artimani T; Amiri I; Najafi R; Shahidi S; Sabec M; Farzadinia P; Zare M; Zahiri M; Soleimani Asl S
Physiol Behav; 2019 Feb; 199():265-272. PubMed ID: 30500334
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury.
Li J; Zhou J; Zhang D; Song Y; She J; Bai C
J Cell Mol Med; 2015 Oct; 19(10):2341-51. PubMed ID: 26177266
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha.
Zhao HX; Wang XL; Wang YH; Wu Y; Li XY; Lv XP; Zhao ZQ; Zhao RR; Liu HR
Basic Res Cardiol; 2010 Jan; 105(1):109-18. PubMed ID: 19597757
[TBL] [Abstract][Full Text] [Related]
11. CSE/H2S system protects mesenchymal stem cells from hypoxia and serum deprivation‑induced apoptosis via mitochondrial injury, endoplasmic reticulum stress and PI3K/Akt activation pathways.
Guo Z; Li CS; Wang CM; Xie YJ; Wang AL
Mol Med Rep; 2015 Aug; 12(2):2128-34. PubMed ID: 25901909
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α.
Ogle ME; Gu X; Espinera AR; Wei L
Neurobiol Dis; 2012 Feb; 45(2):733-42. PubMed ID: 22061780
[TBL] [Abstract][Full Text] [Related]
14. 2,5-hexanedione induces bone marrow mesenchymal stem cell apoptosis via inhibition of Akt/Bad signal pathway.
Sun J; Shi X; Li S; Piao F
J Cell Biochem; 2018 Apr; 119(4):3732-3743. PubMed ID: 29236316
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.
Chen J; Baydoun AR; Xu R; Deng L; Liu X; Zhu W; Shi L; Cong X; Hu S; Chen X
Stem Cells; 2008 Jan; 26(1):135-45. PubMed ID: 17932426
[TBL] [Abstract][Full Text] [Related]
16. Expression of HIF prolyl hydroxylase isozymes in growth plate chondrocytes: relationship between maturation and apoptotic sensitivity.
Terkhorn SP; Bohensky J; Shapiro IM; Koyama E; Srinivas V
J Cell Physiol; 2007 Jan; 210(1):257-65. PubMed ID: 17044072
[TBL] [Abstract][Full Text] [Related]
17. Cytoprotective effect of melatonin against hypoxia/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro.
Wang F; Zhou H; Du Z; Chen X; Zhu F; Wang Z; Zhang Y; Lin L; Qian M; Zhang X; Li X; Hao A
Eur J Pharmacol; 2015 Feb; 748():157-65. PubMed ID: 25281200
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.
Takeda K; Ichiki T; Narabayashi E; Inanaga K; Miyazaki R; Hashimoto T; Matsuura H; Ikeda J; Miyata T; Sunagawa K
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2132-7. PubMed ID: 19762779
[TBL] [Abstract][Full Text] [Related]
19. Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor (HIF)-2alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: evidence that HIF-2alpha has a role in NGF-promoted survival of sympathetic neurons.
Lomb DJ; Desouza LA; Franklin JL; Freeman RS
Mol Pharmacol; 2009 May; 75(5):1198-209. PubMed ID: 19204094
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
